Disorders of carbohydrate metabolism

Handbook of Clinical Neurology

Volumn 86, Issue , 2007, Pages 167-182

  DiMauro, Salvatore ^a   Akman, Orhan ^a   Hays, Arthur P ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649303045     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)86007-6     Document Type: Review

References (105)

1. Aasly J., van Diggelen O.P., Boer A.M., et al. Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms. Eur J Neurol 7 (2000) 111-113
2. Agamanolis D.P., Askari A.D., DiMauro S., et al. Muscle phosphofructokinase deficiency: two cases with unusual polysaccharide accumulation and immunologically active enzyme protein. Muscle Nerve 3 (1980) 456-467
3. Arad M., Benson D.W., Perez-Atayde A.R., et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 109 (2002) 357-362
4. Arad M., Maron B.J., Gorham J.M., et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. New Engl J Med 352 (2005) 362-372
5. Ausems M.G., Verbiest J., Hermans M.P., et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counseling. Eur J Hum Genet 7 (1999) 713-716
6. Bao Y., Kishnani P., Tang T.T., et al. Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme. J Clin Invest 97 (1996) 941-948
7. Bartram C., Edwards R., Clague J., et al. McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases. Hum Mol Genet 2 (1993) 1291-1293
8. Bornemann A., Besser R., Shin Y.S., et al. A mild adult myopathic variant of type IV glycogenosis. Neuromuscul Disord 6 (1996) 95-99
9. Bresolin N., Ro Y.I., Reyes M., et al. Muscle phosphoglycerate mutase (PGAM) deficiency: a second case. Neurology 33 (1983) 1049-1053
10. Bruno C., Manfredi G., Andreu A.L., et al. A splice junction mutation in the alpha-M gene of phosphorylase kinase in a patient with myopathy. Biochem Biophys Res Commun 249 (1998) 648-651
11. Bruno C., van Diggelen O.P., Cassandrini D., et al. Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV). Neurology 63 (2004) 1053-1058
12. Burwinkel B., Rootwelt T., Kvittingen E.A., et al. Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene. Pediat Res 54 (2003) 834-839
13. Burwinkel B., Hu B., Schroers A., et al. Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases. Eur J Hum Genet 11 (2003) 516-526
14. Burwinkel B., Scott J.W., Buhrer C., et al. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet 76 (2005) 1034-1049
15. Chan E.M., Young E.J., Ianzano L., et al. Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nature Genet 35 (2003) 125-127
16. Chan E.M., Omer S., Ahmed M., et al. Progressive myoclonus epilepsy with polyglucosans (Lafora disease). Evidence for a third locus. Neurology 63 (2004) 565-567
17. Chan E.M., Andrade D.M., Franceschetti S., et al. Progressive myoclonus epilpsies: EPM1, EPM2A, EPM2B. Adv Neurol 95 (2005) 47-57
18. Chen Y.T. Glycogen storage diseases. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Basis of Inherited Disease Vol. 1 (2001), McGraw-Hill, New York, NY 1521-1551
19. Cohen-Solal M., Valentin C., Plassa F., et al. Identification of new mutations in two phosphoglycerate kinase (PGK) variants expressing different clinical syndromes: PGK Creteil and PGK Amiens. Blood 84 (1994) 898-903
20. Comi G.P., Fortunato F., Lucchiari S., et al. B-enolase deficiency, a new metabolic myopathy of distal glycolysis. Ann Neurol 50 (2001) 202-207
21. DiMauro S. Myoglobinuria and myopathies of storage disease. In: Conn R.B. (Ed). Current Diagnosis (1985), Saunders, Philadelphia, PA 1037-1042
22. DiMauro S., Hartwig G.B., Hays A.P., et al. Debrancher deficiency: neuromuscular disorder in five adults. Ann Neurol 5 (1979) 422-436
23. DiMauro S., Miranda A.F., Khan S., et al. Human muscle phosphoglycerate mutase deficiency: newly discovered metabolic myopathy. Science 212 (1981) 1277-1279
24. DiMauro S., Miranda A.F., Olarte M., et al. Muscle phosphoglycerate mutase deficiency. Neurology 32 (1982) 584-591
25. DiMauro S., Dalakas M., and Miranda A.F. Phosphoglycerate kinase deficiency: another cause of recurrent myoglobinuria. Ann Neurol 13 (1983) 11-19
26. DiMauro S., Bresolin N., and Hay A.P. Disorders of glycogen metabolism of muscle. Crit Rev Clin Neurobiol 1 (1984) 83-116
27. DiMauro S., Hays A.P., and Tsujino S. Nonlysosomal glycogenoses. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology Vol. II (2004), McGraw-Hill, New York 1535-1558
28. El-Schahawi M., Tsujino S., Shanske S., et al. Diagnosis of McArdle's disease by molecular genetic analysis of blood. Neurology 47 (1996) 579-580
29. El-Schahawi M., Bruno C., Tsujino S., et al. Sudden infant death syndrome (SIDS) in a family with myophosphorylase deficiency. Neuromuscul Disord 7 (1997) 81-83
30. Engel A.G., Hirschhorn R., and Huie M. Acid maltase deficiency. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology Vol. 2 (2004), McGraw-Hill, New York 1559-1586
31. Ewert R., Gulijew A., Wensel R., et al. Die Glykogenose Typ IV seltene Ursache einer Kardiomyopathie - Bericht einer erfolgreichen Herztransplantation. Z Kardiol 88 (1999) 850-856
32. Farrans V.J., Hibbs R.G., Walsh J.J., et al. Cardiomyopathy, cirrhosis of the liver and deposits of a fibrillar polysaccharide. Am J Cardiol 17 (1966) 457-469
33. Ferguson I.T., Mahon M., and Cumming W.J. An adult case of Andersen's disease - type IV glycogenosis. A clinical, histochemical, ultrastructural and biochemical study. J Neurol Sci 60 (1983) 337-351
34. Fernandez-Cadenas I., Andreu A.L., Gamez J., et al. Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease. Neurology 61 (2003) 1432-1434
35. Gambetti P.L., DiMauro S., Hirt L., et al. Myoclonic epilepsy with Lafora bodies. Arch Neurol 25 (1971) 483-493
36. Hadjigeorgiou G.M., Kawashima N., Bruno C., et al. Manifesting heterozygotes in a Japanese family with a novel mutation in the muscle-specific phosphoglycerate mutase (PGAM-M) gene. Neuromuscul Disord 9 (1999) 399-402
37. Hagemans M.L.C., Janssens A., Winkel L.P.F., et al. Late-onset Pompe disease primarily affects quality of life in physical health domains. Neurology 63 (2004) 1688-1692
38. Hagemans M.L.C., Winkel L.P.F., Hop W.C.J., et al. Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology 64 (2005) 2139-2141
39. Haller R.G. Treatment of McArdle disease. Arch Neurol 57 (2000) 923-924
40. Haller R.G., and Lewis S.F. Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. New Engl J Med 324 (1991) 364-369
41. Haller R.G., and Vissing J. Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease. Arch Neurol 59 (2002) 1395-1402
42. Haller R.G., and Vissing J. Functional evaluation of metabolic myopathies. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology Vol. 1 (2004), McGraw-Hill, New York 665-679
43. Haller R.G., and Vissing J. No spontaneous second wind in muscle phosphofructokinase deficiency. Neurology 62 (2004) 82-86
44. Hamano T., Mutoh T., Sugie H., et al. Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation. Neurology 54 (2000) 1188-1190
45. Hays A.P., Hallett M., Delfs J., et al. Muscle phosphofructokinase deficiency: abnormal polysaccharide in a case of late-onset myopathy. Neurology 31 (1981) 1077-1086
46. Horinishi A., Okubo M., Tang N.L., et al. Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III. J Hum Genet 47 (2002) 55-59
47. Kanno T., and Maekawa M. Lactate dehydrogenase M-subunit deficiency: clinical features, metabolic background, and genetic heterogeneities. Muscle Nerve Suppl. 3 (1995) S54-S60
48. Kanno T., Sudo K., Takeuchi I., et al. Hereditary deficiency of lactate dehydrogenase M-subunit. Clin Chim Acta 108 (1980) 267-276
49. Kazemi-Esfarjani P., Skomorowska E., Dysgaard Jensen T., et al. Nonischemic forearm exercise test for McArdle disease. Ann Neurol 52 (2002) 153-159
50. Kiechl S., Kohlendorfer U., Thaler C., et al. Different clinical aspects of debrancher deficiency myopathy. J Neurol Neurosurg Psychiatry 67 (1999) 364-368
51. Kiechl S., Willeit J., Vogel W., et al. Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis. Neuromuscul Disord 9 (1999) 408-410
52. Kissel J.T., Beam W., Bresolin N., et al. Physiologic assessment of phosphoglycerate mutase deficiency: incremental exercise test. Neurology 35 (1985) 828-833
53. Kreuder J., Borkhardt A., Repp R., et al. Inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. New Engl J Med 334 (1996) 1100-1104
54. Lafora G.R. Über das Vorkommen amyloider Korperchen in Innern der Ganglienzellen. Virchows Arch Pathol Anat 205 (1911) 295-303
55. Laforet P., Richard P., Ait Said M., et al. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy and muscular glycogenosis. Ann Neurol 16 (2006) 178-182
56. Lam C., Lee A., Lam Y., et al. DNA-based subtyping of glycogen storage disease type III: mutation and haplotype analysis of the AGL gene in Chinese. Mol Genet Metab 83 (2004) 271-275
57. Lee P.J., Deanfield J.E., Biurch M., et al. Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III. Am J Cardiol 79 (1997) 834-838
58. Lossos A., Meiner Z., Barash V., et al. Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329 Ser mutation in the glycogen-branching enzyme gene. Ann Neurol 44 (1998) 867-872
59. Lucchiari S., Donati M.A., Melis D., et al. Mutational analysis of the AGL gene: five novel mutations in GSD III patients. Hum Mutat 23 (2003) 337
60. Mankodi A., and Ashizawa T. Echo of silence. Silent mutations, RNA splicing, and neuromuscular diseases. Neurology 61 (2003) 1330-1331
61. Martin M.A., Rubio J.C., Wevers R.A., et al. Molecular analysis of myophosphorylase deficiency in Dutch patients with McArdle's disease. Ann Hum Genet 68 (2003) 17-22
62. Martinuzzi A., Sartori E., Fanin M., et al. Phenotype modulators in myophosphorylase deficiency. Ann Neurol 53 (2003) 497-502
63. Matern D., Starzl T.E., Arnaout W., et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 158 Suppl 2 (1999) S43-S48
64. McArdle B. Myopathy due to a defect in muscle glycogen breakdown. Clin Sci 10 (1951) 13-33
65. McConkie-Rosell A., Wilson C., Piccoli D.A., et al. Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease. J Inherit Metab Dis 19 (1996) 51-58
66. Milan D., Jeon J., Looft C., et al. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288 (2000) 1248-1251
67. Miller C.G., Alleyne G.A., and Brooks S. Gross cardiac involvement in glycogen storage disease type III. Br Heart J 34 (1972) 862-864
68. Minassian B.A., Ianzano L., Meloche M., et al. Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy. Neurology 55 (2000) 341-346
69. Morimoto A., Ueda I., Hirashima Y., et al. A novel missense mutation (1060G>C) in the phosphoglycerate kinase gene in a Japanese boy with chronic hemolytic anemia, developmental delay and rhabdomyolysis. Br J Haematol 122 (2003) 1009-1013
70. Moses S.W., and Parvari R. The variable presentations of glycogen storage disease type IV: A review of clinical, enzymatic and molecular studies. Curr Mol Med 2 (2002) 177-188
71. Moses S.W., Wanderman K.L., Myroz A., et al. Cardiac involvement in glycogen storage disease type III. Eur J Paed 148 (1989) 764-766
72. Nakajima H., Kono N., Yamasaki T., et al. Genetic defect in muscle phosphofructokinase deficiency. Abnormal splicing of the muscle phosphofructokinase gene due to a point mutation at the 5′-splice site. J Biol Chem 265 (1990) 9392-9395
73. Nakajima H., Raben N., Hamaguchi T., et al. Phosphofructokinase deficiency: past, present and future. Curr Mol Med 2 (2002) 197-212
74. Nambu M., Kawabe K., Fukuda T., et al. A neonatal form of glycogen storage disease type IV. Neurology 61 (2003) 392-394
75. Nase S., Kunze K.P., Sigmund M., et al. A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. In vivo detection by heart muscle biopsy. Eur Heart J 16 (1995) 1698-1704
76. Ookawara T., Dave V., Willems P., et al. Retarded and aberrant splicings caused by single exon mutation in a phosphoglycerate kinase variant. Arch Biochem Biophys 327 (1996) 35-40
77. Ponzetto Zimmerman C., and Gold A.M. Glycogen branching enzyme in Lafora myoclonus epilepsy. Biochem Med 28 (1982) 83-93
78. Quinlivan R., and Beynon R.J. Pharmacological and nutritional treatment for McArdle's disease (glycogen storage disease type V). The Cochrane Database of Systematic Reviews (2004) CD003458.
79. Quintanas B., Sanchez-Andrade A., Teijera S., et al. A new rare mutation (691delCC/insAAA) in exon 17 of the PYGM gene causing McArdle disease. Arch Neurol 61 (2004) 1108-1110
80. Raben N., Sherman J., Miller F., et al. A 5′ splice junction mutation leading to exon deletion in an Ashkenazi Jewish family with phosphofructokinase deficiency (Tarui disease). J Biol Chem 268 (1993) 4963-4967
81. Raben N., Danon M.J., Lu N., et al. Surprises of genetic engineering: a possible model of polyglucosan body disease. Neurology 56 (2001) 1739-1745
82. Rossignol A.M., Meyer M., Rossignol B., et al. La myocardiopathie de la glycogenose type III. Arch Fr Pediatr 36 (1979) 303-309
83. Schroder J.M., Dodel R., Weis J., et al. Mitochondrial changes in muscle phosphoglycerate kinase deficiency. Clin Neuropath 15 (1996) 34-40
84. Shen J., and Chen Y. Molecular characterization of glycogen storage disease type III. Curr Mol Med 2 (2002) 167-175
85. Sherman J.B., Raben N., Nicastri C., et al. Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenosis VII - and their population frequency. Am J Hum Genet 55 (1994) 305-313
86. Slonim A.E., Balone L., Ritz S., et al. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr 137 (2000) 283-285
87. Swoboda K.J., Specht L., Jones H.R., et al. Infantile phosphofructokinase deficiency with arthrogryposis: clinical benefit of a ketogenic diet. J Pediatr 131 (1997) 932-934
88. Tang T.T., Segura A.D., Chen Y., et al. Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis. Acta Neuropathol 87 (1994) 531-536
89. Tarui S., Okuno G., Ikua Y., et al. Phosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis. Biochem Biophys Res Commun 19 (1965) 517-523
90. Tay S.K.H., Akman H.O., Chung W.K., et al. Fatal infantile neuromuscular presentation of glycogen storage disease type IV. Neuromuscul Disord 14 (2004) 253-260
91. Tonin P., Lewis P., Servidei S., et al. Metabolic causes of myoglobinuria. Ann Neurol 27 (1990) 181-185
92. Tonin P., Bruno C., Shanske S., et al. Phosphorylase b kinase deficiency in adult-onset myopathy. Neurology 42 (1992) 387
93. Toscano A., Tsujino S., Vita G., et al. Molecular basis of muscle phosphoglycerate mutase (PGAM-M) deficiency in the Italian kindred. Muscle Nerve 19 (1996) 1134-1137
94. Tsujino S., Shanske S., and DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease). New Engl J Med 329 (1993) 241-245
95. Tsujino S., Shanske S., Sakoda S., et al. The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency. Am J Hum Genet 52 (1993) 472-477
96. Tsujino S., Shanske S., Goto Y., et al. Two mutations, one novel and one frequently observed, in Japanese patients with McArdle's disease. Hum Mol Genet 3 (1994) 1005-1006
97. Tsujino S., Shanske S., Carroll J.E., et al. Double trouble: combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both loci. Neuromuscul Disord 5 (1995) 263-266
98. Van den Hout J., Van der Ploeg A.T., Cromme-Dijkhuis A., et al. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 356 (2000) 397-398
99. Van den Hout J., Kamphoven J.H.J., Winkel L.P.F., et al. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 113 (2004) e448-e457
100. Vissing J., and Haller R.G. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. New Engl J Med 349 (2003) 2503-2509
101. Vissing J., and Haller R.G. A diagnostic cycle test for McArdle's disease. Ann Neurol 4 (2003) 539-542
102. Vissing J., Schmalbruch H., Haller R.G., et al. Muscle phosphoglycerate mutase deficiency with tubular aggregates: effect of dantrolene. Ann Neurol 46 (1999) 274-277
103. Wang J., Stuckey J.A., Wishart M.J., et al. A unique carbohydrate binding domain targets the Lafora disease phosphatase to glycogen. J Biol Chem 277 (2002) 2377-2380
104. Wehner M., Clemens P.R., Engel A.G., et al. Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit. Hum Mol Genet 3 (1994) 1983-1987
105. Winkel L.P.F., Van den Hout J., Kamphoven J.H.J., et al. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Ann Neurol 55 (2004) 495-502